🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Stocks rally on vaccine hopes, crude oil gains

Published 16/07/2020, 05:03 am
© Reuters.
EUR/USD
-
USD/JPY
-
USD/SEK
-
XAU/USD
-
US500
-
DJI
-
JP225
-
HK50
-
GS
-
JPM
-
AMZN
-
WFC
-
GC
-
LCO
-
CL
-
IXIC
-
FTEU3
-
CSI300
-
SXNP
-
SXPP
-
SXTP
-
MRNA
-
ZM
-

(Adds oil, gold settlement prices)

* COVID vaccine hopes drive risk-on sentiment

* Economic, crude oil data help growth outlook

* Simmering U.S.-Sino tensions remain a concern

By Herbert Lash and Marc Jones

NEW YORK/LONDON, July 15 (Reuters) - World shares strode to four-month highs on Wednesday as hopes for a coronavirus vaccine offset rising U.S.-China tensions and helped lift the euro and oil prices.

Asian markets were choppy after more barbs between Beijing and Washington over Hong Kong but gains of almost 2% in European bourses and Wall Street's advance pushed aside concerns about the still growing number of COVID cases.

An experimental vaccine produced by biotech start-up Moderna Inc MRNA.O drew safe immune responses in all 45 healthy volunteers, an early stage trial showed on Tuesday. There were reports on Wednesday that a separate University of Oxford trial also looked good. Treasury yields rose and the yield curve steepened, indicating a wider spread between long- and short-term interest rates, as hopes for a vaccine boosted risk appetite and upbeat economic data released on Wednesday added to the optimism.

"The market is trading fairly 'risk on' on vaccine hopes," said Gennadiy Goldberg, an interest rate strategist at TD Securities in New York. "It's largely COVID news driving the price action recently."

U.S. industrial production, manufacturing output and plant capacity rose more than expected in June and there was a bigger- than-expected draw in U.S. crude and refined products last week as demand edges up. broad FTSEurofirst 300 index .FTEU3 rose 1.65%, as growth-sensitive sectors such as travel & leisure .SXTP , miners .SXPP and industrial companies .SXNP led gains.

Moderna surged 9% to a record high after its experimental vaccine produced high levels of virus-killing antibodies, bolstering hopes it could prove effective in later stages of testing. Wall Street, the Dow Jones Industrial Average .DJI rose 0.7%, the S&P 500 .SPX gained 0.86% and the Nasdaq Composite .IXIC added 0.61%.

Stocks that have benefited from widespread lockdowns, including Amazon AMZN.O and Zoom Video Communications ZM.O , slid and limited Nasdaq's gains. Amazon was poised for a third consecutive session of losses.

Hopes of progress this week towards a deal on the European Union's 750 billion-euro COVID recovery fund helped sentiment in Europe. The euro traded above $1.1430 EUR= for the first time since March, and Italy and Spain's bond market borrowing costs came down again. .EU /FRX GVD/EUR

The European Central Bank started a two-day meeting, though no major announcement is expected when it concludes on Thursday. euro EUR= was last up 0.09% at $1.1406.

Chinese shares fell 1.3% .CSI300 and Hong Kong .HSI ended flat, after U.S. President Donald Trump ordered an end to Hong Kong's special status under U.S. law to punish China for its "oppressive actions" against the former British colony.

That prompted a retaliatory warning from China's foreign ministry that "Hong Kong affairs are purely China's internal affairs and no foreign country has the right to interfere." Nikkei .N225 and Australia's benchmark index remained upbeat, finishing up 1.6% and 1.9%, respectively.

Investment bank Goldman Sachs (NYSE:GS) GS.N was also pointing higher after reporting higher quarterly profits following the COVID crisis trading boom. JPMorgan (NYSE:JPM), Citi and Wells Fargo (NYSE:WFC) had reported huge Q2 profit drops on Tuesday and set aside a collective $28 billion for loan losses. ALERT

The dollar was on the defensive, particularly against risk-sensitive currencies, following the news of progress in vaccine development. /FRX

Sweden's crown SEK= vaulted to its highest versus the greenback since February 2019 and the risk-sensitive Australian dollar popped to a one-month high at $0.70 AUD=D4 .

The yen JPY= was down 0.26% at $106.9500.

The Bank of Japan kept its monetary policy steady, as expected, on Wednesday though it warned that uncertainty over the economic outlook was "extremely high" due to various risks, including rising coronavirus infections in Tokyo, which was put on "red alert" on Wednesday. rose on the sharp drop in U.S. inventories, but further gains were limited as the Organization of the Petroleum Exporting Countries and allies are set to ease supply curbs from August as the global economy recovers from the pandemic.

Brent crude LCOc1 settled up 89 cents at $43.79 a barrel, while U.S. crude CLc1 rose 91 cents to settle at $41.20 a barrel.

Gold prices held above $1,800 an ounce as the surge in coronavirus cases and renewed U.S.-China tensions bolstered safe-haven demand, but the rally in stocks capped the advance.

U.S. gold futures GCv1 added 40 cents to settle at$1,813.80. Spot gold XAU= rose 0.19% to $1,810.89.

<^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^ Global assets

http://tmsnrt.rs/2jvdmXl Global currencies vs. dollar

http://tmsnrt.rs/2egbfVh Emerging markets

http://tmsnrt.rs/2ihRugV MSCI All Country Wolrd Index Market Cap

http://tmsnrt.rs/2EmTD6j Bulls in the China shop

https://tmsnrt.rs/2WlCDoC

^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^>

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.